Last night, the Ambassador of Italy to the United States, H.E. Marco Peronaci, hosted the latest meeting of the “Villa Firenze Talks” series in Washington, D.C., on the topic of healthy lifespan. The debate featured contributions from Alicia Jackson, Director of ARPA-H (Advanced Research Projects Agency for Health), the federal agency for cutting-edge biomedical research; Italian Professor Camillo Ricordi, one of the world’s leading researchers in transplants and diabetology and Director of the Cellular Transplant Division at the University of Miami; and Federico Rampini, a columnist for Corriere della Sera and one of the most prominent figures in Italian journalism.
“At a time when healthcare systems around the world are facing increasing pressures from chronic diseases and rising healthcare costs, this meeting highlighted how scientific innovation, combined with a healthy lifestyle and local medical care, can produce significant results for public health,” commented Ambassador Peronaci. “Italy and the United States, thanks to their research centers, can play a leading role in translating research into concrete improvements for citizens’ health,” he added.
The underlying theme of the conversation, moderated by Esther Krofah – Vice President for Health at the Milken Institute – was how to identify a way to bring together science, policy, and innovation for a better future of health and aging. Leading Italian and American experts in biomedical research, public health, nutritional sciences, and biotechnology were in attendance.
By examining advances in diagnostics, regenerative medicine, artificial intelligence, advanced biology, and nutritional science, the discussion underscored the importance of a new approach to healthcare, shifting from reactive treatment to proactive prevention. Such an approach can ultimately lead to earlier diagnosis and long-term resilience and would have significant impact on the financial sustainability of our healthcare systems.
